Health care expenditures of patients with major depressive disorder and post traumatic stress disorder

Crystal-Peters, Jodi; Chang, Shang‐Tzen; Long, Sara; Tretiak, R.

doi:10.1016/s0924-9338(02)80651-4

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…highlighted that PTSD is second to MDD in terms of financial costs and burden of disease. The findings were supported in an analysis of a US private health service database of health consumption costs demonstrating that costs for patients with PTSD were greater than for those with MDD alone [67]. Comorbid MDD and PTSD significantly increased the costs above a single disorder.…”

Section: Treatmentmentioning

confidence: 73%

Posttraumatic stress disorder: the intersection of epidemiology and individual psychobiological adaptation

McFarlane¹

2003

Current Opinion in Psychiatry

View full text Add to dashboard Cite

Purpose of reviewThis review is written against the backdrop of the attack of September 11 and the case in the UK where veterans of recent wars are suing the Ministry of Defence for its failure to provide ongoing treatment. These two events highlight the demand for knowledge about the risks of exposure to traumatic events and the effectiveness of interventions in the aftermath. Furthermore, posttraumatic stress disorder has now been part of psychiatric nomenclature for over 20 years and it is important to reflect on the frontiers of knowledge and to ensure that we are not entering a phase of repetitive recycling of information. Recent findingsPosttraumatic stress disorder in non-compensable settings has been found to be a major source of disability and disadvantage that demands attention in any public health policy. The ability to provide early treatment depends on defining individuals who are at risk as soon as possible after exposure. The intensity of the symptoms of dissociation about the event during the first month was more important than peri-traumatic dissociation as had been suggested by earlier research. Epidemiological research of community-based samples and event-specific traumas remain the backbone of investigating the risk factors such as sex in the onset of the disorder. Few advances have occurred in the domain of treatment. The apparent benefits of atypical antipsychotics present an interesting development in the literature. SummaryThe evidence demonstrates the predictable morbidity of exposure to traumatic events. The challenge is to implement systems of care that address the evidence that falls outside some of the more conventional constructs of psychiatric morbidity.

show abstract

Section: Treatmentmentioning

confidence: 73%

Posttraumatic stress disorder: the intersection of epidemiology and individual psychobiological adaptation

McFarlane¹

2003

Current Opinion in Psychiatry

View full text Add to dashboard Cite

show abstract

Health care expenditures of patients with major depressive disorder and post traumatic stress disorder

Abstract: Health care expenditures of patients with major depressive disorder and post traumatic stress disorder concomitant anticholinergic (8%) compared to risperidone patients (19%).

Cited by 1 publication

References 0 publications

Posttraumatic stress disorder: the intersection of epidemiology and individual psychobiological adaptation

Posttraumatic stress disorder: the intersection of epidemiology and individual psychobiological adaptation

Contact Info

Product

Resources

About